July 26, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Jimmy McNamara, Esq.
Office of Life Sciences
| Re: | OS Therapies Incorporated Registration Statement on Form S-1 (No. 333-279839) |
Ladies and Gentlemen:
On behalf of OS Therapies Incorporated, a Delaware corporation (the “Company”), we enclose the Company’s request for acceleration of the above-referenced Registration Statement to 4:45 p.m., Eastern Time, on Tuesday, July 30, 2024, or as soon as practicable thereafter.
Please advise the undersigned of the effectiveness of the Registration Statement.
| Very truly yours, | |
| /s/ Spencer G. Feldman | |
| Spencer G. Feldman |
| cc: | Paul A. Romness, MPH |
July 26, 2024
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn.: | Jimmy McNamara, Esq. |
Office of Life Sciences
| Re: | OS Therapies Incorporated Registration Statement on Form S-1 (No. 333-279839) |
Ladies and Gentlemen:
OS Therapies Incorporated hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 4:45 p.m., Eastern Time, on Tuesday, July 30, 2024, or as soon as practicable thereafter.
| Very truly yours, | ||
| OS Therapies Incorporated | ||
| By: | /s/ Paul A. Romness | |
| Paul A. Romness | ||
| President and Chief Executive Officer | ||